In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo.
Where this comes from
- Record sourced from PubMed, PMID 41490499.
- Also identified by DOI 10.7326/ANNALS-25-04963-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Hematology: [Formula: see text].
Medical subject headings
- Pyridones
- Pyrazoles
- Factor Xa Inhibitors
- Venous Thromboembolism
- Anticoagulants